Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ATMR

Altimar Acquisition Corp. II (ATMR) Stock Price, News & Analysis

About Altimar Acquisition Corp. II Stock (NYSE:ATMR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$9.35
$10.53
52-Week Range
N/A
Volume
355,800 shs
Average Volume
146,007 shs
Market Capitalization
$454.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altimar Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATMR Stock News Headlines

RFAI RF Acquisition Corp II
Ares Acquisition Corporation II (AACT)
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
Altimar Acquisition Corp. II Class A
PMGM Priveterra Acquisition Corp.
See More Headlines

ATMR Stock Analysis - Frequently Asked Questions

Altimar Acquisition Corp. II (ATMR) raised $24 million in an initial public offering (IPO) on Friday, August 5th 2016. The company issued 3,200,000 shares at $7.50 per share. National Securities Corporation served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Altimar Acquisition Corp. II investors own include Atreca (BCEL), Black Diamond Therapeutics (BDTX), Editas Medicine (EDIT), F5 (FFIV), Galileo Acquisition (GLEO), Harpoon Therapeutics (HARP) and LogicBio Therapeutics (LOGC).

Company Calendar

Today
9/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Fabricated Structural Metal Products
Sub-Industry
N/A
Current Symbol
NYSE:ATMR
CIK
1836176
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.08
Quick Ratio
4.08

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
43,125,000
Free Float
N/A
Market Cap
$454.11 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:ATMR) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners